Self · Medpace Holdings, Inc. · Medpace Holdings, Inc. - Common Stock
Sale
Disclosed range starting at $15K
Disclosed 29 days after execution (STOCK Act deadline: 45)
First recorded trade by this actor in this security
No clustered activity in the dataset
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 36 | Ewald Stephen PGeneral Counsel & Corp. Secy. | Open-market sale | SELL | $859K 1,245 sh | Nov 2, 2026 traded Oct 29, 2026 | |
| 35 | Burwig Susan EExec. VP, Operations | Open-market sale | SELL | $2.67M 3,940 sh | Oct 28, 2026 traded Oct 27, 2026 | |
| 9 | Burwig Susan EExec. VP, Operations | Option exercise | M | — 328 sh | Oct 28, 2026 traded Oct 26, 2026 | |
| 46 | Burwig Susan EExec. VP, Operations | Open-market sale | SELL | $10.87M 16.1K sh | Oct 28, 2026 traded Oct 26, 2026 | |
| 12 | Burwig Susan EExec. VP, Operations | Option exercise | M | $55K 328 sh | Oct 28, 2026 traded Oct 26, 2026 | |
| 15 | Burwig Susan EExec. VP, Operations | Option exercise | M | $450K 2,700 sh | Oct 23, 2026 traded Oct 21, 2026 | |
| 9 | Burwig Susan EExec. VP, Operations | Option exercise | M | — 2,700 sh | Oct 23, 2026 traded Oct 21, 2026 | |
| 21 | Burwig Susan EExec. VP, Operations | Option exercise | M | — 3,000 sh | Oct 14, 2026 traded Oct 12, 2026 | |
| 15 | Burwig Susan EExec. VP, Operations | Option exercise | M | $500K 3,000 sh | Oct 14, 2026 traded Oct 12, 2026 | |
| 15 | Burwig Susan EExec. VP, Operations | Option exercise | M | $333K 2,000 sh | Oct 9, 2026 traded Oct 7, 2026 | |
| 17 | Burwig Susan EExec. VP, Operations | Option exercise | M | — 2,000 sh | Oct 9, 2026 traded Oct 7, 2026 | |
| 33 | Troendle August J.Director, President & CEO, 10% Owner | Open-market sale | SELL | $17.29M 27.8K sh | Sep 25, 2026 traded Sep 24, 2026 | |
| 29 | Troendle August J.Director, President & CEO, 10% Owner | Open-market sale | SELL | $10.11M 16.1K sh | Sep 25, 2026 traded Sep 23, 2026 | |
| 33 | Troendle August J.Director, President & CEO, 10% Owner | Open-market sale | SELL | $30.79M 49.0K sh | Sep 23, 2026 traded Sep 22, 2026 | |
| 33 | Troendle August J.Director, President & CEO, 10% Owner | Open-market sale | SELL | $13.64M 21.9K sh | Sep 23, 2026 traded Sep 21, 2026 | |
| 42 | Kraft Robert O.Director | Open-market sale | SELL | $2.38M 3,858 sh | Aug 28, 2026 traded Aug 26, 2026 | |
| 27 | Kraft Robert O.Director | Option exercise | M | $325K 3,858 sh | Aug 28, 2026 traded Aug 26, 2026 | |
| 9 | Kraft Robert O.Director | Option exercise | M | — 3,858 sh | Aug 28, 2026 traded Aug 26, 2026 | |
| 27 | McCarthy Cornelius P. IIIDirector | Open-market sale | SELL | $690K 1,140 sh | Aug 13, 2026 traded Aug 11, 2026 | |
| 31 | McCarthy Cornelius P. IIIDirector | Open-market sale | SELL | $465K 795 sh | Aug 11, 2026 traded Aug 7, 2026 |
Read directly from the primary public document; every field below is as reported by the filer.
Midpoint = (low + high) / 2. Used only to rank and sum ranges; the true value can be anywhere in the range.
= $32,501
Gilbert Ray Cisneros, Jr. reported a sale of Medpace Holdings, Inc. - Common Stock. Members report a value range, not an exact amount, and do not report share counts or prices. Dates are as entered by the filer. A trade report is not evidence of wrongdoing.
No field has changed since this record was first ingested.
No material filings recorded for this issuer.